Usefulness of high mobility group box 1 protein as a plasma biomarker in patient with peripheral artery disease

Acta Medica Okayama

Volumn 68, Issue 3, 2014, Pages 157-162

  Oozawa, Susumu ^a   Sanoa, Shunji ^a   Nishibori, Masahiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis disease; HMGB1; Peripheral artery fibrinogen

Indexed keywords

BIOLOGICAL MARKER; FIBRINOGEN; HIGH MOBILITY GROUP B1 PROTEIN;

ADULT; AGED; BLOOD; FEMALE; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; PERIPHERAL OCCLUSIVE ARTERY DISEASE;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; FIBRINOGEN; HMGB1 PROTEIN; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE;

EID: 84903826019     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wang H, Yang H and Tracey KJ: Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med (2004) 255: 320-331.
2. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A and Tracey KJ: HMG-1 as a late mediator of endotoxin lethality in mice. Science (1999) 285: 248-251.
3. Ueno H, Matsuda T, Hashimoto S, Amaya F, Kitamura Y, Tanaka M, Kobayashi A, Maruyama I, Yamada S, Hasegawa N, Soejima J, Koh H and Ishizaka A: Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med (2004) 170: 1310-1316.
4. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA and Billiar TR: The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia- reperfusion. J Exp Med (2005) 201: 1135-1143.
5. Liu K, Mori S, Takahashi HK, Tomono Y, Wake H, Kanke T, Sato Y, Hiraga N, Adachi N, Yoshino T and Nishibori M: Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarc tion induced by transient ischemia in rats. FASEB J (2007) 21: 3904-3916.
6. Oozawa S, Mori S, Kanke T, Takahashi H, Liu K, Tomono Y, Asanuma M, Miyazaki I, Nishibori M and Sano S: The Effects of HMGB1 on Ischemia-Reperfusion Injury in the Rat Heart. Circ J (2008) 72: 1178-1184.
7. Li W, Sama AE and Wang H: Role of HMGB1 in cardiovascular diseases. Curr Opin Pharmacol (2006) 6: 130-135.
8. Basta G: Receptor for advanced glycation endproducts and athero sclerosis: From basic mechanisms to clinical implications. Athero sclerosis (2008) 196: 9-21.
9. Kalinina N, Agrotis A, Antropova Y, DiVitto G, Kanellakis P, Kostolias G, Ilyinskaya O, Tararak E and Bobik A: Increased expression of the DNA-binding cytokine HMGB1 in human athero sclerotic lesions: role of activated macrophages and cytokines. Arterioscler Thromb Vasc Biol (2004) 24: 2320-2325.
10. Porto A, Palumbo R, Pieroni M, Aprigliano G, Chiesa R, Sanvito F, Maseri A and Bianchi ME: Smooth muscle cells in human athero sclerotic plaques secrete and proliferate in response to high mobil ity group box 1 protein. FASEB J (2006) 20: 2565-2566.
11. Cuccurullo C, Iezzi A, Fazia ML, De Cesare D, Di Francesco A, Muraro R, Bei R, Ucchino S, Spigonardo F, Chiarelli F, Schmidt AM, Cuccurullo F, Mezzetti A and Cipollone F: Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arterioscler Thromb Vasc Biol. (2006)26: 2716-2723.
12. Mannucci PM: Recent progress in the pathophysiology of fibrino- gen. Eur Heart J (1995) 16: 25-30.
13. Ernst E: Fibrinogen: Its Emerging Role as a Cardiovascular Risk Factor. Angiology (1994) 45: 87-93.
14. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH and Suffredini AF: Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood (2003) 101: 2652-2660.
15. Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med (1999)340: 115-126.
16. Libby P, Ridker P and Maseri A: Inflammatory and atherosclerosis. Circulation (2002) 105: 1135-1143.
17. Blake GJ and Ridker PM: Novel clinical markers of vascular wall inflammation. Circ Res (2001) 89: 763-771.
18. Naito M, Hyashi T, Kuzuya M, Funaki C, Asai K and Kuzuya F: Effects of fibrinogen and fibrin on the migration of vascular smooth muscle cells in vitro. Atherosclerosis (1990) 83: 9-14.
19. KoenigW: Fibrinogen in cardiovascular disease: an update. Thromb Haemost (2003) 89: 601-609.
20. Afilalo J, Duque G, Steele R, Jukema JW, Craen AJ and Eisenberg M: Statins for secondary prevention in elderly patients: a hierar chical Bayesian meta-analysis. J Am Coll Cardiol (2008) 51: 37-45.
21. Roy SN, Mukhopadhyay G and Redman CM: Regulation of fibrinogen assembly Transfection of Hep G2 cells with B beta cDNA spe cifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem (1990) 265: 6389-6393.